Neurogene (NGNE) Non Operating Income (2013 - 2026)

Neurogene's Non Operating Income history runs 14 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• Quarterly Non Operating Income fell 26.19% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 36.55% YoY) and the FY2025 annual result came in at $13.0 million, up 73.93% from the prior year.
• Non Operating Income was $2.4 million for Q1 2026 at Neurogene, down from $2.8 million in the prior quarter.
• Across five years, Non Operating Income topped out at $19.3 million in Q4 2023 and bottomed at -$22000.0 in Q3 2022.
• A 5-year average of $2.8 million and a median of $2.0 million in 2024 frame the typical range for Non Operating Income.
• Peak annual rise in Non Operating Income reached 192910.0% in 2023, while the deepest fall reached 1500.0% in 2023.
• Neurogene's Non Operating Income stood at -$10000.0 in 2022, then jumped by 192910.0% to $19.3 million in 2023, then plunged by 89.64% to $2.0 million in 2024, then surged by 39.84% to $2.8 million in 2025, then declined by 13.56% to $2.4 million in 2026.
• Business Quant data shows NGNE's Non Operating Income at $2.4 million in Q1 2026, $2.8 million in Q4 2025, and $2.8 million in Q3 2025.